INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,312 | -1.6% | 19,149 | -0.7% | 0.01% | -22.2% |
| Q1 2024 | $1,334 | -6.9% | 19,277 | -3.6% | 0.01% | -10.0% |
| Q4 2023 | $1,433 | +12.4% | 20,007 | -18.3% | 0.01% | +25.0% |
| Q3 2023 | $1,275 | -13.4% | 24,485 | +5.3% | 0.01% | -20.0% |
| Q2 2023 | $1,473 | +3.6% | 23,263 | -11.4% | 0.01% | 0.0% |
| Q1 2023 | $1,422 | +112.6% | 26,257 | +107.8% | 0.01% | +100.0% |
| Q4 2022 | $669 | -99.9% | 12,638 | -18.3% | 0.01% | 0.0% |
| Q3 2022 | $720,000 | -3.6% | 15,471 | +18.3% | 0.01% | 0.0% |
| Q2 2022 | $747,000 | -27.8% | 13,080 | -22.7% | 0.01% | 0.0% |
| Q1 2022 | $1,035,000 | +48.1% | 16,911 | +26.6% | 0.01% | +66.7% |
| Q4 2021 | $699,000 | +75.6% | 13,353 | +24.9% | 0.00% | +50.0% |
| Q3 2021 | $398,000 | +11.5% | 10,687 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $357,000 | +43.4% | 8,739 | +19.3% | 0.00% | +100.0% |
| Q1 2021 | $249,000 | +22.7% | 7,327 | -23.9% | 0.00% | 0.0% |
| Q1 2018 | $203,000 | -4.2% | 9,628 | -34.2% | 0.00% | 0.0% |
| Q4 2017 | $212,000 | +20.5% | 14,638 | +223.0% | 0.00% | 0.0% |
| Q2 2016 | $176,000 | +58.6% | 4,532 | +13.7% | 0.00% | 0.0% |
| Q1 2016 | $111,000 | -31.9% | 3,986 | +31.9% | 0.00% | 0.0% |
| Q4 2015 | $163,000 | +20.7% | 3,022 | -10.4% | 0.00% | 0.0% |
| Q3 2015 | $135,000 | +382.1% | 3,374 | +279.1% | 0.00% | – |
| Q2 2015 | $28,000 | +100.0% | 890 | +53.7% | 0.00% | – |
| Q1 2015 | $14,000 | +40.0% | 579 | +0.5% | 0.00% | – |
| Q4 2014 | $10,000 | 0.0% | 576 | -18.2% | 0.00% | – |
| Q3 2014 | $10,000 | -9.1% | 704 | +4.3% | 0.00% | – |
| Q2 2014 | $11,000 | – | 675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |